Pediatric Endocrinology Diabetes and Metabolism

Stres oksydacyjny i insulinooporność u libijskich osób z zespołem Downa: ocena i porównanie z grupą osób zdrowych

Amani Mohamed Tayeh 1
,
Osama Hussien El-Deeb 2
,
Mohamed Hamza Ahmeida 3, 4

  1. Department of Biomedical Science, Division of Life Science, Libyan Academy for Postgraduate Studies,
    Al-Bayda, Libya

  2. Department of Biochemistry, Omar Al-Mukhtar University, Al-Bayda, Libya

  3. Department of Nutrition, Faculty of Public Health, Benghazi University, Benghazi, Libya

  4. Master of Clinical Biochemistry Program (LIMU), Libyan International University, Benghazi, Libya

Pediatr Endocrinol Diabetes Metab 2026; 32 (2):

DOI: https://doi.org/10.5114/pedm.2026.161190
Data publikacji online: 2026/06/05
Plik artykułu
0423_Oxidative stress (1).pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Danopoulos S, Deutsch GH, Dumortier C, et al. Lung disease manifestations in Down syndrome. Am J Physiol Lung Cell Mol Physiol 2021; 321: L892–L899. doi: 10.1152/ajplung.00434.2020.
  2. Lakovschek IC, Streubel B, Ulm B. Natural outcome of trisomy 13, trisomy 18, and triploidy after prenatal diagnosis. Am J Med Genet A 2011; 155A: 2626–2633. doi: 10.1002/ajmg.a.34284.
  3. Buczyńska A, Sidorkiewicz I, Krętowski AJ, Zbucka-Krętowska M. The role of oxidative stress in trisomy 21 phenotype. Cell Mol Neurobiol 2023; 43: 3943–3963. doi: 10.1007/s10571-023-01417-6.
  4. Strydom A, Dickinson MJ, Shende S, et al. Oxidative stress and cognitive ability in adults with Down syndrome. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 76–80. doi: 10.1016/j.pnpbp.2008.10.006.
  5. Pizzino G, Irrera N, Cucinotta M, et al. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev 2017; 2017: 8416763. doi: 10.1155/2017/8416763.
  6. He J, Li T, Chen J, et al. Plasma antioxidant enzymes and lipoperoxidation status in children with Down syndrome. Clin Biochem 2016; 49: 61–65. doi: 10.1016/j.clinbiochem.2015.08.026.
  7. Gaweł S, Wardas M, Niedworok E, Wardas P. Dialdehyd malonowy (MDA) jako wskaźnik procesów peroksydacji lipidów w organizmie [Malondialdehyde (MDA) as a lipid peroxidation marker]. Wiad Lek 2004; 57: 453–455. [Article in Polish].
  8. Dierssen M, Fructuoso M, Martínez de Lagrán M, et al. Down syndrome is a metabolic disease: altered insulin signaling mediates peripheral and brain dysfunctions. Front Neurosci 2020; 14: 670. doi: 10.3389/fnins.2020.00670.
  9. Artioli T. Understanding obesity in Down’s syndrome children. J Obes Metab 2017; 1: 1000101.
  10. Lee CM, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol 2008; 61: 646–653. doi: 10.1016/j.jclinepi.2007.08.012.
  11. Van Dijk SB, Takken T, Prinsen EC, Wittink H. Different anthropometric adiposity measures and their association with cardiovascular disease risk factors: a meta-analysis. Neth Heart J 2012; 20: 208–218. doi: 10.1007/s12471-011-0237-7.
  12. Xi B, Zong X, Kelishadi R, et al. International waist circumference percentile cutoffs for central obesity in children and adolescents aged 6 to 18 years. J Clin Endocrinol Metab 2020; 105: e1569–e1583. doi: 10.1210/clinem/dgz195.
  13. Zhang FL, Ren JX, Zhang P, et al. Strong association of waist circumference (WC), body mass index (BMI), waist-to-height ratio (WHtR), and waist-to-hip ratio (WHR) with diabetes: a population-based cross-sectional study in Jilin Province, China. J Diabetes Res 2021; 2021: 8812431. doi: 10.1155/2021/8812431.
  14. Hurrle S, Hsu WH. The etiology of oxidative stress in insulin resistance. Biomed J 2017; 40: 257–262. doi: 10.1016/j.bj.2017.06.007.
  15. Real de Asua D, Parra P, Costa R, et al. A cross-sectional study of the phenotypes of obesity and insulin resistance in adults with down syndrome. Diabetes Metab J 2014; 38: 464–471. doi: 10.4093/dmj.2014.38.6.464.
  16. Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev 2018; 98: 2133–2223. doi: 10.1152/physrev.00063.2017.
  17. Abdesselam A, Zidoum H, Zadjali F, et al. Estimate of the HOMA-IR cut-off value for identifying subjects at risk of insulin resistance using a machine learning approach. Sultan Qaboos Univ Med J 2021; 21: 604–612. doi: 10.18295/squmj.4.2021.030.
  18. Akhigbe R, Ajayi A. The impact of reactive oxygen species in the development of cardiometabolic disorders: a review. Lipids Health Dis 2021; 20: 23. doi: 10.1186/s12944-021-01435-7.
  19. Singh A, Ghai N, Bedi PMS. Molecular mechanisms involved in insulin resistance: recent updates and future challenges. In: Infante M, ed. Evolving concepts in insulin resistance. London: IntechOpen; 2022. doi: 10.5772/intechopen.104806.
  20. Hetman M, Barg E, Placzkowska S. Comparative analysis of obesity prevalence, antioxidant and oxidant status in children with Down syndrome – a sibling-controlled study. Pediatr Endocrinol Diabetes Metab 2023; 29: 134–142. doi: 10.5114/pedm.2023.131513.
  21. United Nations. Convention on the rights of the child. New York: United Nations; 1991.
  22. Wee SO, Pitetti KH, Goulopoulou S, et al. Impact of obesity and Down syndrome on peak heart rate and aerobic capacity in youth and adults. Res Dev Disabil 2015; 36C: 198–206. doi: 10.1016/j.ridd.2014.10.002.
  23. Wernio E, Kłosowska A, Kuchta A, et al. Analysis of dietary habits and nutritional status of children with Down syndrome in the context of lipid and oxidative stress parameters. Nutrients 2022; 14: 2390. doi: 10.3390/nu14122390.
  24. Magge SN, Zemel BS, Pipan ME, et al. Cardiometabolic risk and body composition in youth with Down syndrome. Pediatrics 2019; 144: e20190137. doi: 10.1542/peds.2019-0137.
  25. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–358. doi: 10.1016/0003-2697(79)90738-3.
  26. Parisotto EB, Garlet TR, Cavalli VL, et al. Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome. Res Dev Disabil 2014; 35: 1228–1236. doi: 10.1016/j.ridd.2014.03.013.
  27. Chávez CJ, Ortega P, D’Escrivan A, et al. Body mass index changes and lipid peroxidation in adults with Down’s syndrome. Int Med Rev Down Syndr 2012; 16: 19–25. doi: 10.1016/S2171-9748(12)70021-1.
  28. Cordeiro AMT, Singulani MP, Talib LL, Forlenza OV. Down syndrome and Alzheimer’s disease: oxidative stress in the neurodegenerative process. J Alzheimers Dis 2025; 105: 258–267. doi: 10.1177/13872877251326291.
  29. Meguid NA, Eltohamy AM, Anwar M, et al. Efficacy of selected treadmill training programme on oxidative stress in adolescents with Down syndrome. East Mediterr Health J 2014; 19 Suppl 3: S131–S137.
  30. Shields N, Downs J, de Haan JB, et al. What effect does regular exercise have on oxidative stress in people with Down syndrome? A systematic review with meta-analyses. J Sci Med Sport 2018; 21: 596–603. doi: 10.1016/j.jsams.2017.10.015.
  31. Tenneti N, Dayal D, Sharda S, et al. Concentrations of leptin, adiponectin and other metabolic parameters in non-obese children with Down syndrome. J Pediatr Endocrinol Metab 2017; 30: 831–837. doi: 10.1515/jpem-2016-0422.
  32. Yahia S, El-Farahaty RM, El-Hawary AK, et al. Leptin, insulin and thyroid hormones in a cohort of Egyptian obese Down syndrome children: a comparative study. BMC Endocr Disord 2012; 12: 22. doi: 10.1186/1472-6823-12-22.
  33. Foerste T, Sabin M, Reid S, Reddihough D. Understanding the causes of obesity in children with trisomy 21: hyperphagia vs physical inactivity. J Intellect Disabil Res 2016; 60: 856–864. doi: 10.1111/jir.12259.
  34. Mazurek D, Wyka J. Down syndrome – genetic and nutritional aspects of accompanying disorders. Rocz Panstw Zakl Hig 2015; 66: 189–194.
  35. AlDarwish N, AlSaab A, AlQusair D, et al. Dietary pattern, physical activity and body composition of children with and without Down syndrome – a case control study. J Intellect Disabil 2025; 29: 24–39. doi: 10.1177/17446295231219618.
ZGŁASZANIE PRAC
Udostępnij
without publication fees
Zintergrowane z
integrated with publons
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications